Announcements Trials

Browse Landscape

Sponsor

Conditions

Breast Neoplasms 6 Malignant Solid Neoplasm 1 Inflammatory Breast Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms, Male 1 Bladder Urothelial Carcinoma 1 Advanced Breast Carcinoma 1 Adenocarcinoma Of Esophagus 1

Interventions

Doxorubicin 33 Ifosfamide 23 Gemcitabine 19 pazopanib 18 Cyclophosphamide 16 Radiotherapy 15 pembrolizumab 13 Filgrastim 12 Docetaxel 12 Bevacizumab 10 Vincristine 9 Sirolimus 9 Irinotecan 9 Etoposide 9 olaratumab 7 eribulin 7 Sorafenib 7 Radiation 7 temsirolimus 6 Temozolomide 6 Mesna 6 Magnetic Resonance Spectroscopy 6 Cisplatin 6 tazemetostat 5 cixutumumab 5 Trabectedin 5 Radiosurgery 5 Nivolumab 5 Ipilimumab 5 Granulocyte Colony-Stimulating Factor 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Sarcoma × trastuzumab biosimilar HLX02 × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡